Study of the risk factors for the progression of diabetic kidney disease
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000029858
- Lead Sponsor
- Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
Under 20 y/o
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method At the time of patient registration, registration (0 M), 12 M, 24 M, 36 M, the following indices are measured. Vitamin D, PTH, AcSDKP, Type IV C, Bteta-2MG, Kim 1, Ngal, 8OHDG, eGFR, UACR, U-podocalyxin. Also, we will also measure urinary podocalyxin (PCX) at the time of visit only for patients who obtained permission.
- Secondary Outcome Measures
Name Time Method